NTLA earnings call for the period ending December 31, 2020.
News & Analysis: Intellia Therapeutics
Investors are looking forward to what could be a great year for the biotechnology company.
NTLA earnings call for the period ending September 30, 2020.
NTLA earnings call for the period ending June 30, 2020.
Could this promising gene-editing company make you rich?
Which of these companies that are developing cutting-edge gene-editing technologies is the better buy for investors?
Which gene editing stock wins this matchup?
An existing partner is doubling down on the gene editing platform.
Editas has more favorable terms for its collaborations with big pharma companies, but it still has a long way to go.
NTLA earnings call for the period ending March 31, 2020.